UB Paderborn / Katalog / Suche / in CDI

Delphi, non-RAND modified Delphi, RAND/UCLA appropriateness method and a novel group awareness and consensus methodology for consensus measurement: a systematic literature review

Current medical research and opinion, 2020-11, Vol.36 (11), p.1873-1887

Jandhyala, Ravi

2020

Link zum Volltext

Verfügbarkeit prüfen

Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument

Health and quality of life outcomes, 2021-09, Vol.19 (1), p.229-229, Article 229

Jandhyala, Ravi

2021

Link zum Volltext

Verfügbarkeit prüfen

Neutral theory: applicability and neutrality of using generic health-related quality of life tools in diseases or conditions where specific tools are available

BMC medical research methodology, 2021-04, Vol.21 (1), p.86-86, Article 86

Jandhyala, Ravi

2021

Link zum Volltext

Verfügbarkeit prüfen

Neutral theory: applicability and neutrality of clinical study endpoints where a disease-specific instrument is available

BMC medical research methodology, 2023-05, Vol.23 (1), p.121-121, Article 121

Jandhyala, Ravi

2023

Link zum Volltext

Verfügbarkeit prüfen

Concordance between the schedule for the evaluation of individual quality of life-direct weighting (SEIQoL-DW) and the EuroQoL-5D (EQ-5D) measures of quality of life outcomes in adults with X-linked hypophosphatemia

Orphanet journal of rare diseases, 2022-02, Vol.17 (1), p.81-81, Article 81

Jandhyala, Ravi

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians

Frontiers in pharmacology, 2022-02, Vol.13, p.842431-842431

Jandhyala, Ravi

2022

Link zum Volltext

Verfügbarkeit prüfen

The effect of adding real-world evidence to regulatory submissions on the breadth of population indicated for rare disease medicine treatment by the European Medicines Agency

Journal of pharmaceutical policy and practice, 2022-05, Vol.15 (1), p.36-36, Article 36

Jandhyala, Ravi

2022

Link zum Volltext

Verfügbarkeit prüfen

Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry [version 1; peer review: 1 approved, 1 approved with reservations]

F1000 research, 2022, Vol.11, p.813

Jandhyala, Ravi

2022

Link zum Volltext

Verfügbarkeit prüfen

Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry [version 2; peer review: 2 approved]

F1000 research, 2022-01, Vol.11, p.813-813

Jandhyala, Ravi

2022

Link zum Volltext

Verfügbarkeit prüfen

FGF23 and its role in X-linked hypophosphatemia-related morbidity

Orphanet journal of rare diseases, 2019-02, Vol.14 (1), p.58-58, Article 58

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Rapid-Onset Oral Fentanyl Formulations vs. Oral Morphine for Cancer-Related Breakthrough Pain: A Meta-Analysis of Comparative Trials

Journal of pain and symptom management, 2013-10, Vol.46 (4), p.573-580

2013

Link zum Volltext

Verfügbarkeit prüfen

Commercial impact of adding real-world evidence to clinical trials at regulatory approval: a Markovian-like transition model

Current medical research and opinion, 2023-12, Vol.ahead-of-print (ahead-of-print), p.1-8

Jandhyala, Ravi

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of a definition for real-world evidence using the Jandhyala method for observing consensus opinion among medical affairs pharmaceutical physicians

Current medical research and opinion, 2023-12, Vol.ahead-of-print (ahead-of-print), p.1-8

Jandhyala, Ravi

2023

Link zum Volltext

Verfügbarkeit prüfen

Guest editor foreword: real-world evidence and medical affairs

Current medical research and opinion, 2023-12, Vol.39 (12), p.1537-1539

Jandhyala, Ravi

2023

Link zum Volltext

Verfügbarkeit prüfen

Development, validation and implementation of the medical affairs pharmaceutical physician work-related quality of life instrument

Current medical research and opinion, 2023-12, Vol.ahead-of-print (ahead-of-print), p.1-8

Jandhyala, Ravi

2023

Link zum Volltext

Verfügbarkeit prüfen

The multiple stakeholder approach to real-world evidence (RWE) generation: observing multidisciplinary expert consensus on quality indicators of rare disease patient registries (RDRs)

Current medical research and opinion, 2021-07, Vol.37 (7), p.1249-1257

Jandhyala, Ravi

2021

Link zum Volltext

Verfügbarkeit prüfen

Comment on: “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments”

Drug safety, 2019-12, Vol.42 (12), p.1515-1516

Jandhyala, Ravi

2019

Link zum Volltext

Verfügbarkeit prüfen

A medicine adoption model for assessing the expected effects of additional real-world evidence (RWE) at product launch

Current medical research and opinion, 2021-09, Vol.37 (9), p.1645-1655

Jandhyala, Ravi

2021

Link zum Volltext

Verfügbarkeit prüfen

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study

Orphanet journal of rare diseases, 2020-06, Vol.15 (1), p.1-172, Article 172

2020

Link zum Volltext

Verfügbarkeit prüfen

Concordance between the schedule for the evaluation of individual quality of life-direct weighting measures of quality of life outcomes in adults with X-linked hypophosphatemia

Orphanet journal of rare diseases, 2022-02, Vol.17 (1)

Jandhyala, Ravi

2022

Link zum Volltext

Verfügbarkeit prüfen

Design, validation and implementation of the post-acute instrument

Health and quality of life outcomes, 2021-09, Vol.19 (1)

Jandhyala, Ravi

2021

Link zum Volltext

Verfügbarkeit prüfen

Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method

Current medical research and opinion, 2023-12, Vol.ahead-of-print (ahead-of-print), p.1-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument

Pharmaceutical medicine, 2022-02, Vol.36 (1), p.47-57

Jandhyala, Ravi

2022

Link zum Volltext

Verfügbarkeit prüfen

Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes-Systematic Literature Review and Expert Consensus

Vaccines (Basel), 2021-10, Vol.9 (11), p.1255

2021

Link zum Volltext

Verfügbarkeit prüfen

Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers

Pharmaceutical medicine, 2020-04, Vol.34 (2), p.127-134

Jandhyala, Ravi

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Delphi, non-RAND modified Delphi, RAND/UCLA appropriateness method and a novel group awareness and consensus methodology for consensus measurement: a systematic literature review

Design, validation and implementation of the post-acute (long) COVID-19 quality of life (PAC-19QoL) instrument

Neutral theory: applicability and neutrality of using generic health-related quality of life tools in diseases or conditions where specific tools are available

Neutral theory: applicability and neutrality of clinical study endpoints where a disease-specific instrument is available

Concordance between the schedule for the evaluation of individual quality of life-direct weighting (SEIQoL-DW) and the EuroQoL-5D (EQ-5D) measures of quality of life outcomes in adults with X-linked hypophosphatemia

Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians

The effect of adding real-world evidence to regulatory submissions on the breadth of population indicated for rare disease medicine treatment by the European Medicines Agency

Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry [version 1; peer review: 1 approved, 1 approved with reservations]

Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry [version 2; peer review: 2 approved]

FGF23 and its role in X-linked hypophosphatemia-related morbidity

Efficacy of Rapid-Onset Oral Fentanyl Formulations vs. Oral Morphine for Cancer-Related Breakthrough Pain: A Meta-Analysis of Comparative Trials

Commercial impact of adding real-world evidence to clinical trials at regulatory approval: a Markovian-like transition model

Development of a definition for real-world evidence using the Jandhyala method for observing consensus opinion among medical affairs pharmaceutical physicians

Guest editor foreword: real-world evidence and medical affairs

Development, validation and implementation of the medical affairs pharmaceutical physician work-related quality of life instrument

The multiple stakeholder approach to real-world evidence (RWE) generation: observing multidisciplinary expert consensus on quality indicators of rare disease patient registries (RDRs)

Comment on: “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments”

A medicine adoption model for assessing the expected effects of additional real-world evidence (RWE) at product launch

The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study

Concordance between the schedule for the evaluation of individual quality of life-direct weighting measures of quality of life outcomes in adults with X-linked hypophosphatemia

Design, validation and implementation of the post-acute instrument

Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method

Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument

Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes-Systematic Literature Review and Expert Consensus

Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers

Suchergebnisse filtern